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Aim. The aim of this paper is to investigate if the insertion of the pelvic drainage tube via the perineal wound could be considered
as an independent risk factor for perineal healing disorders, after abdominoperineal resection for rectal malignancy. Patients and
Methods. The last two decades, 75 patients underwent elective abdominoperineal resection for malignancy. In 42 patients (56%),
the pelvic drain catheter was inserted through the perineal wound (PW group), while in the remaining 33 (44%) through a
puncture skin wound of the perineum (SW group). Patients’ data with respect to age (P = 0.136), stage (P>0.05), sex (P = 0.188)
and comorbidity (P = 0.128) were similar in both groups. 25 patients (PW versus SW: 8 versus 17, P = 0.0026) underwent
neoadjuvantradio/chemotherapy.Results.Theoverallmorbidityratewas36%,butasigniﬁcantincreasewasrevealedinPW group
(52.4% versus 9%, P = 0.0007). In 33.3% of the patients in the PW group, perineal healing was delayed, while in the SW group,no
delay was noted. Perineal healing disorders were revealed as the main source of increased morbidity in this group. Conclusion.T h e
insertion of the pelvic drain tube through the perineal wound should be considered as an independent risk factor predisposing to
perineal healing disorders.
1.Introduction
The abdominoperineal resection (APR) was ﬁrst described
by Miles in 1908, but early clinical trials reported operative
morbidity rates as high as 40% [1–4]. Nissan et al. [5]
reported an overall morbidity rate of 50–60% in patients
undergoing APR for carcinoma. After the rectum is excised,
thesacralcavityformsalargewoundareathatcannotbeeﬃ-
cientlyreduced.Thatareaispronetoretentionandinfection.
Besides, it is well documented that postoperative complica-
tions of the perineal wound and their long-term residuals
comprise the major morbidity factor, especially when com-
bined with neoadjuvant radio/chemotherapy [6–8].
According to published data, some authors recommend
the pelvic drain externalization through an abdominal stab
incision, while others bring out the tubes directly through
the perineum—either via a separate skin incision or via the
perineal wound [9–11]. With regards to our technique, we
believe that a perineal externalization site produces better
results due to the gravity. To our knowledge, there are no
studies up to date concerning the eﬀects of the pelvic drain
externalization site on the morbidity rates.
The aim of this study is to investigate whether the inser-
tion of the pelvic drainage tube viathe perineal wound could
be considered as an independent risk factor for perineal
healing disorders, following APR for rectal malignancy.
2. Patients andMethods
Between1991 and2010, electiveabdominoperineal resection
for rectal carcinoma was performed in 75 patients (47 males2 International Journal of Surgical Oncology
and 28 females) with a mean age of 69 years (range, 22–82
years). The preoperative assessment for all patients included
blood tests, chest X-ray, colonoscopy, and abdominal com-
putedtomography.Since1995,pelvicMRIwasalsoroutinely
used for staging purposes. The mean distance of the tumors
from the dentate line was 3.1cm (max: 4cm, min: 0.5cm).
Preoperative bowel preparation with polyethylene glycol
was routinely performed. Antibiotic prophylaxis consisted
of intravenous 2nd generation cephalosporin and metron-
idazole, given at induction. During procedures lasting more
than 2 hours, another dose was administered. No further
postoperative antibiotics were used, unless a postoperative
complication had arisen that needed treatment. All pro-
cedures were performed by one senior colorectal surgeon.
Before the beginning of the procedure, randomization of the
patient to either one of the two groups found place using a
computer-generated ballot.
With regards to the technique used, we performed both
abdominal andperineal approacheswiththe patientin mod-
iﬁed lithotomy position. The abdomen was entered through
a midline incision, extending from the pubis cephalad to
just above the umbilicus. This approach allows adequate
visualization of the abdomen, as well as the extension
of the incision cephalad, should the splenic ﬂexure need
mobilization. A total mesorectal excision with high ligation
of the inferior mesenteric vessels and preservation of the
pelvic plexuses was performed.
Ninety-two percent of the interventions (69 patients; 38
of the Perineal Wound a n d3 1o ft h eSkin Wound group)
were performed with curative intent, whereas in 6 patients
(8%), 4 of the PW and 2 of the SW group, the procedure
was palliative. In one patient of the Perineal Wound group,
the posterior vaginal wall was also resected en bloc with
the rectum. In a further Perineal Wound group patient,
two metastases of the right hepatic lobe were enucleated
using radiofrequency ablation. With regards to the Skin
Wound group, one patient underwent total hysterectomy
and resection of the posterior vaginal wall, one underwent
resection of the posterior bladder wall, and a third patient
underwent resection of the posterior vaginal wall.
A 30-Fr passive drainage was inserted and the peritoneal
pelvic ﬂoor was reconstructed. This device, also known as
gravity drainage system, consisted of a plain tube and a
350mL volumetric bag (Figure 1). The perineal wound was
primarily closed in a two-layer fashion. In 42 patients (56%),
the pelvic drain was inserted through the perineal wound,
whereas in the remaining 33 patients (44%), the drain was
inserted via a puncture skin wound to the left lateral portion
of the perineum. The puncturesite used was due to surgeon’s
preference. Dermatological anomalies that would not allow
the positioning of the puncture wound at this point were
not observed in any patient. The pelvic drain was left in situ
until either the daily ﬂuid amount was less than 50mL, or
the drain had been in situ for 5–7 days and the patient was
ready for discharge. In the latter case, the drain was removed
irrespective of the daily output amount of the drain.
Twenty-ﬁve patients, 8 of the Perineal Wound and 17 of
theSkinWound group(P = 0.0026),underwentneoadjuvant
chemoradiation. Surgery was performed six to eight weeks
Figure 1: Type of a 30-Fr passive drainage system.
after preoperative radio/chemotherapy (Table 1). Patients’
data with respect to age, sex, and comorbidity were similar
in both groups (Table 2).
3.StatisticalAnalysis
Fisher’s exact test was used for the comparisons between
proportions. Allthestatisticalanalyseswereperformedusing
the SPSS v.15.0 statistical package (SPSS Inc, Chicago, IL,
USA), enhanced with the modules exact tests.
4. Results
All patients were followed-up in our clinic on a weekly basis
following their discharge for the ﬁrst month and monthly
thereafter. During follow-up, all patients had their baseline
observations taken and a thorough examination of the
perinealwoundwasperformedbytheoperatingsurgeonand
one assistant surgeon. Signs of localized infection, cellulitis,
or delayed healing (such as redness, discoloration, swelling,
warmth, etc.) were noted and recorded.
Most tumors in both groups were classiﬁed as BII
according to Duke’s classiﬁcation and most of them were
moderately diﬀerentiated. The detailed classiﬁcation and
diﬀerentiation of all tumors in the two groups is presented
in Table 3.
Postoperative complications were observed in 22 patients
of the Perineal Wound as well as in 5 patients of the Skin
Wound group. With regards to surgery-speciﬁc complica-
tions, 20 were noted in patients of the Perineal Wound group,
as well as 3 in patients of the Skin Wound group (PW
versus SW: 47.6% versus 9%, P = 0.0002). The incidence
of perineal wound healing disorders was signiﬁcantly higher
in the Perineal Wound group (PW versus SW: 33.3% versus
0, P<0.001). In detail, 14 patients of the Perineal Wound
showed a delay in perineal wound healing; in 11 of these
patients, the perineal wound healing process was completed
in 25–40 days (mean 31.2 days), while in three patients
a permanent ﬁstula was formed. In the Skin Wound group
the mean time until complete perineal wound healing was
10 days and no case of healing disorder was noted. On
the other hand, the number of patients who underwent
neoadjuvant radio/chemotherapy was signiﬁcantly higher inInternational Journal of Surgical Oncology 3
Table 1: Patients treated by APR for a low rectal cancer (n = 75).
Group PW (n = 42) SW (n = 33) P value Signiﬁcance level
Age∗ 67.2 (22–81) 71.3 (41–80) 0.157 NS
Sex ♂/♀ 26/16 21/12 0.1878 NS
Tumor loc.∗∗ 3.1 (0.5–4)
Indication
Curative 38 (90%) 31 (94%) 0.2935 NS
Palliative 4 (10%) 2 (6%) 0.2935 NS
Neo-adjuvant RT/CT 8 17 0.0026 Sig.
Adjuvant RT/CT 21 8 0.0147 Sig.
∗yrs: value I median (range).
∗∗cm from the dentate line: value is mean (range).
(NS: non-signiﬁcant; P value >0.05; Sig.: signiﬁcant, P value <0.05).
Table 2: Risk factors associated with increased morbidity after APR; comparison of the study groups.
Group PW (n = 42) SW (n = 33) P value Signiﬁcance level
Age (>55yrs) 29 26 0.136 NS
Comorbidity 30 27 0.128 NS
Diabetes 11 7 0.191 NS
Cardiopulmonary dis. 4 5 0.212 NS
Vascular dis. 8 9 0.153 NS
Obesity (B.M.I. >30kg/m2) 12 9 0.203 NS
Neo-adjuvant RT/CT 8 17 0.0026 Sig.
NS: non-signiﬁcant, P value >0.05; Sig.: signiﬁcant, P value <0.05.
the Skin Wound group (SW versus PW: 51.5% versus 19%,
P = 0.0026), and it is widely known that the incidence
of wound healing abnormalities is reported to be higher
in these patients. The rate of nonspeciﬁc, postoperative
complications was exactly the same in both groups (Table 4).
The overall morbidity rate was 36%, but the statistical
analysis revealed a signiﬁcant increase in the Perineal Wound
group (PW versus SW: 52.4% versus 9%, P = 0.0007).
5-year follow-up was completed for 49 patients, with a
nonsigniﬁcant comparison between the study groups (SW
versus PW: 26 versus 23, P = 0.1336). With regards to the
survival rates, no signiﬁcance was revealed after the pair-
wise comparison (SW versus PW: 73.07% versus 73.9%, P =
0.253), while the overall rate was 73.4% (Table 5).
5. Discussion
The abdominoperineal resection of the rectum is one of the
most demanding procedures in gastrointestinal surgery and
has undergone only slight technical modiﬁcations since its
ﬁrst description [12–15].
In patients undergoing APR and especially for carci-
noma, multiple speciﬁc complications may arise either in the
short or long term. According to published data, the overall
morbidity ranges from 50 to 60% after an APR [16]. Murrell
at al. [17] reported that the most common immediate
postoperative complication, with a frequency of 32%, is
the formation of an intra-abdominal or pelvic abscess. In
our study the incidence of this complication was extremely
low, as only one case of abscess in the presacral space
was noted, which was treated successfully with computed
tomography-guided drainage and intravenous antibiotics.
Other known complications include nerve injury, ureteric
injury, complications from the colostomy site, as well as
perineal wound complications [18, 19].
In the past, when blunt dissection was used with
little appreciation to the ﬁne pelvic anatomy, sexual dys-
function was seen in up to 75% of men and 40% of
women, while bladder dysfunction was seen up to 80%
of cases. Nowadays, following the introduction of TME,
these rates—even though inﬂuenced by age, tumor location,
and comorbidity—are reported to be 10–30% for sexual
dysfunction and less than 5% for bladder dysfunction [20,
21]. Moreover, postoperative radiation tends to exacerbate
male sexual dysfunction [22]. In our study, 2 cases (2.7%)
o fu r i n a r yb u tn oc a s eo fs e x u a ld y s f u n c t i o nw a sn o t e d ,a s
sharp dissection in the proper planes helped avoiding injury
to the nerve plexuses.
The perineal wound poses a unique risk, predisposing
to major postoperative complications. Despite improved
surgical techniques, the rates of perineal wound dehiscence
are reported to be higher than 10%, as it was also shown in
our data. Furthermore, it is observed in 30–40% of patients
who undergo neoadjuvant radiation [23–26]. The anatomy
of the pelvic ﬂoor and the inherent potential risk of infection
secondary to rectal surgery are associated with a high rate4 International Journal of Surgical Oncology
Table 3: Staging and diﬀerentiation.
Group PW (n = 42) SW (n = 33) P value Signiﬁcance level
Staging (Duke’s)
In situ 2 — 0.310 NS
A3 3 0.311 NS
BI 6 5 0.254 NS
BII 14 13 0.165 NS
CI 3 3 0.311 NS
CII 11 7 0.191 NS
D3 2 0.351 NS
Diﬀerentiation NS
Well 10 4 0.107 NS
Moderate 28 23 0.189 NS
Poor 4 6 0.149 NS
NS: non-signiﬁcant, P value >0.05.
Table 4: Complications, morbidity, and mortality.
Group PW (n = 42) SW (n = 33) P value Signiﬁcance level
Complications 22 5 0.0007 Sig.
Surgical (speciﬁc) 20 3 0.0002 Sig.
Abdominal wound dehiscence 2 2
Pelvic abscess∗ 1—
Ostomy necrosis∗∗ —1
Evisceration/reoperation 1 —
Perineal healing disorders 16 — <0.001 Sig.
Delay in perineal healing 14 —
Perineal wound dehiscence 2 —
Medical (nonspeciﬁc) 2 2 0.374 NS
Pneumonia 1 —
Urinary dysfunction 1 1
Atrial ﬁbrillation — 1
Morbidity 52.4% 15.2% 0.0007 Sig.
Mortality 0
Overall morbidity 36%
∗In the presacral space, treated with CT-guided drainage.
∗∗treated with primary relocation.
(NS: non-signiﬁcant, P value >0.05; Sig.: signiﬁcant, P value <0.05).
of perineal healing abnormalities following an APR. Besides,
perioperative chemoprophylaxis fails to provide suﬃcient
protection, because vessel ligature and electrocoagulation
result in reduced perfusion and consequent disorders in
microcirculation of the sacral cavity [27].
A confounding issue is the diﬀerent opinions as to what
risk factors impair the perineal wound healing. According
to Christian et al. [28], higher rates of major wound
complications were associated with increased body mass
index, diabetes, and stage, while preoperative radiation
and primary closure were not associated with increased
complications. On the other hand, Luna-P´ erez et al. [29]
demonstrated that the main cause of morbidity was perineal
wound infection, inﬂuenced by postoperative radio +/−
chemotherapy administration and patient age over 55 years.
In our patient group, the overall morbidity rate was
36%, while perineal healing disorder was noted to be the
most common postoperative complication (59.3% of all
case complications). Primary healing of the perineal wound,
meaning no formation of seroma or hematoma and no
signs of inﬂammation, was seen in 78.7% of patients. In
the Perineal Wound group, the morbidity was signiﬁcantly
higher compared to the Skin Wound group (52.4%; 22/42 of
patients, P = 0.0007). Perineal wound healing abnormalities
were the main source of increased morbidity in this group
(72.8%; 16/22 of complicated cases, P = 0.001). There wereInternational Journal of Surgical Oncology 5
Table 5: Local recurrence and survival.
Patients (n)S W P W O v e r a l l P value∗ Signiﬁcance level
Compl. 5-year follow-up 26 23 49 0.1336 NS
Deaths 7 6 13 0.2831 NS
Cause of death Time after APR (months)
LR∗∗ 1 1 2 12, 24
LR∗∗ + hepatic metastases — 1 1 6
Hepatic metastases 3 2 5 12, 12, 14, 18,38
Brain metastases 1 — 1 24
Lung + hepatic metastases 1 1 2 18, 24
Hepatic + brain metastases 1 — 1 24
Stroke — 1 1 36
Survival (%) 73.07 73.9 73.4 0.253 NS
Local Recurrence (%) 3.8 8.7 6.1 0.357 NS
∗SW versus PW.
∗∗LR: local recurrence.
NS: non-signiﬁcant, P value >0.05; Sig.: signiﬁcant, P value <0.05.
14cases(33.3%)ofdelayedperinealhealing,aswellas2cases
(4.8%) of perineal wound infection/dehiscence, which were
treated conservatively.
Apart from the pelvic drain externalization site, patients
in both groups showed no statistically signiﬁcant diﬀerences
withregardsto population data, comorbidities, disease stage,
and intraoperative conditions. As mentioned before, these
parametershavebeenreportedtoaﬀectperinealwoundheal-
ing in many publications [30, 31]. Moreover, it is shown that
even though the number of patients who underwent neo-
adjuvantradiationwassigniﬁcantlyhigherintheSkinWound
group, the rate of perineal wound healing abnormalities was
signiﬁcantly lower in these patients compared to those of
the Perineal Wound group. This fact correlates with recently
published studies suggesting the lack of any relation between
pelvic irradiation and perineal healing abnormalities [26].
According to these ﬁndings, it is clearly demonstrated that
the insertion of the pelvic drain tube through the perineal
wound constitutes an independent risk factor aﬀecting per-
inealwoundhealing,whichresultsinincreasedpostoperative
morbidity ratesin patients undergoingAPRforrectalcancer.
6. Conclusion
The insertion of the pelvic drain tube through the perineal
wound should be considered as an independent risk factor
following an APR, predisposing to perineal healing disor-
ders.
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